Skip to main content
SpringerLink
Log in

Gemcitabine/cisplatin

Lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Liu L-F, et al. Effective response to crizotinib of concurrent KIF5B-MET and METCDR2- rearranged non-small cell lung cancer: A case report. World Journal of Clinical Cases 10: 2529-2536, No. 8, 16 Mar 2022. Available from: URL: http://doi.org/10.12998/wjcc.v10.i8.2529

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gemcitabine/cisplatin. Reactions Weekly 1906, 209 (2022). https://doi.org/10.1007/s40278-022-15099-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-15099-2

Search

Navigation